Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

Implementation RSV Immunization Study (IRIS) Ended

2025-521801-42-00 Healthy infants receiving an RSV immunization to preven 6 2025-08-27
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening);… Ended

2024-519000-27-00 Hypertension 5 2025-07-17
A Phase 2 Study of CAL101 in Patients with Idiopathic Pulmonary Fibrosis Ended

2024-518339-12-00 Idiopathic Pulmonary Fibrosis 4 2025-07-08
A long-term study to monitor the health status of people with cystic fibrosis who took part in a previous study with BI 3720931 (LenticlairT… Ended

2023-504909-37-00 Cystic fibrosis 9 2025-07-03
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moder… Ended

2025-520503-27-00 Asthma 1 2025-07-01
Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extra… Ended

2024-516304-42-00 Patients with connective tissue diseases at high risk o 4 2025-05-30
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled… Ended

2024-516815-26-00 Chronic rhinosinusitis with nasal polyps 5 2025-05-30
A dose finding study with an anti-TSLP antibody (GSK5784283) in adults aged 18 to 75 years of age with uncontrolled asthma. Ended

2024-518321-15-00 Asthma 4 2025-05-30
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled… Ended

2024-516814-39-00 Chronic rhinosinusitis with nasal polyps 5 2025-05-20
A Phase I/IIa Study of Roginolisib in combination with dostarlimab with or without docetaxel in Advanced NSCLC (PULMO-01) Ended

2024-517741-14-00 advanced non-squamous non-small cell lung cancer (NSCLC 9 2025-04-22
A study for GSK3862995B in healthy participants and participants with Chronic Obstructive Pulmonary Disease Ended

2023-506880-32-01 Pulmonary Disease, Chronic Obstructive 1 2025-04-14
A Proof of Concept study to assess the efficacy, safety and tolerability of itepekimab (antiIL33 mAb) in participants with chronic rhinosi… Ended

2024-515576-12-00 Respiratory tract diseases 4 2025-03-20
EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) Ended

2024-515255-38-00 SEPSIS 4 2025-03-12
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation t… Ended

2023-510458-18-00 Asthma 6 2025-03-11
Long-term, open-label study of SAR447537 (INBRX-101) in adults with alpha-1 antitrypsin deficiency emphysema Ended

2023-508137-14-00 Alpha-1 Antitrypsin Deficiency (AATD) Emphysema 4 2025-03-11
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight (ATTAIN-OSA) Ended

2024-515905-25-00 Overweight or Obesity 5 2025-01-29
A trial to learn how safe AZD8630 is and how well it works in adults with uncontrolled asthma. Ended

2024-514228-18-00 Asthma in adults who remain uncontrolled despite medium 4 2025-01-16
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Subjects 12 Months of Age and Older Ended

2023-509563-24-00 Cystic Fibrosis 5 2025-01-08
A Phase 1b/2a, open-label single ascending doses and multiple ascending doses study in participants with Pi*ZZ AATD Ended

2024-511981-36-00 Alpha-1 antitrypsin deficiency (AATD) 9 2025-01-06
VAXXAIR TRIAL: In-depth Immunological Analysis of Airway Immunity following Nasal Live Attenuated and Intramuscular Influenza Vaccine A ran… Ended

2023-506166-31-01 Influenza 6 2024-12-23
A Study to Assess the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) in Adults with Refractory or Unexplained Chronic … Ended

2024-515026-86-00 Refractory or Unexplained Chronic Cough 4 2024-12-18
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis Ended

2023-509069-19-00 idiopathic pulmonary fibrosis 4 2024-12-12
A clinical study investigating OM-85 efficacy and safety in children suffering from Recurrent Wheezing Ended

2024-511083-90-00 Recurrent wheezing 4 2024-10-03
A Phase 2, Double-blind, Placebo-controlled, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma Ended

2023-508039-29-00 Moderate-to-severe Asthma 4 2024-09-16